Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.32 USD | +1.35% | -0.27% | -9.23% |
11/04 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
03/04 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.